SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-19-004223
Filing Date
2019-07-22
Accepted
2019-07-22 09:30:14
Documents
3
Period of Report
2019-07-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ipix_8k.htm 8-K 15089
2 EXCLUSIVE LICENSE AGREEMENT ipix_ex101.htm EX-10.1 194108
3 PRESS RELEASE ipix_ex991.htm EX-99.1 12510
  Complete submission text file 0001477932-19-004223.txt   223077
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37357 | Film No.: 19964656
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences